Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_assertion description "[We tested the hypothesis that levosimendan, an inodilator that acts through calcium sensitization, opening of ATP-dependent potassium channels and phosphodiesterase III inhibition, improves cardiac function and survival in double transgenic rats harboring human renin and angiotensinogen genes (dTGRs), a model of angiotensin II (Ang II)-induced hypertensive heart failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_assertion evidence source_evidence_curated NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_assertion SIO_000772 20811386 NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_assertion wasDerivedFrom ctd_human-20130708 NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_assertion wasGeneratedBy ECO_0000218 NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP7999.RAdmAG9_oCe5fEKudHcOwv6OjMICRAa9HB4tdy__mGGcE130_provenance.